Propanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen via POP1 Joint Research & Drug Discovery Program

Propanc Biopharma, Inc. announced that successful production of a synthetic recombinant version of the proenzyme trypsinogen was completed via the Proenzyme Optimization Project 1 oint research and drug discovery program.